SNN

施乐辉
NYSE

实时行情|Nasdaq Last Sale

39.42
-0.26
-0.66%
盘后: 39.42 0 0.00% 16:00 07/02 EDT
开盘
39.78
昨收
39.68
最高
39.96
最低
39.36
成交量
59.84万
成交额
--
52周最高
52.26
52周最低
26.07
市值
172.57亿
市盈率(TTM)
28.81
分时
5日
1月
3月
1年
5年

分析师评级

3位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测

分析师预测SNN价格均价为46.57,最高价位48.70,最低价为43.00。

EPS

SNN 新闻

更多
FTSE struggles for gains after another dire warning over the economy
MarketWatch · 2天前
Declining Stock and Solid Fundamentals: Is The Market Wrong About Smith & Nephew plc (LON:SN.)?
Simply Wall St. · 2天前
Is Smith & Nephew plc (SNN) A Good Stock To Buy?
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. We at Insider Monkey have plowed through 821 13F filings that hedge funds and well-known value investors are
Insider Monkey · 06/24 20:28
Smith+Nephew announces new milestone with its OXINIUM Advanced Bearing System implants surpassing two million procedures
PR Newswire · 06/18 13:00
Smith+Nephew's Regeneten Implant CE Mark'd
Seeking Alpha - Article · 06/16 11:14
Smith+Nephew's REGENETEN Bioinductive Implant Receives CE Mark
Smith+Nephew (NYSE: SNN) is pleased to announced that its REGENETEN Bioinductive Implant has successfully received CE Mark certification allowing the implant to now be used and sold in key European markets.
Benzinga · 06/16 09:30
Smith+Nephew's revolutionary REGENETEN™ Bioinductive Implant receives CE Mark
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, is pleased to announced that its REGENETEN Bioinductive Implant has successfully received CE Mark certification allowing the implant to now be used and sold in key European markets. With
PR Newswire · 06/16 07:00
Smith+Nephew launches INTELLIO Connected Tower Solution for improved operating room efficiency
PR Newswire · 06/11 13:00

所属板块

医疗设备、用品及经销
+0.80%
医疗设备和用品
+0.92%

热门股票

代码
价格
涨跌幅

SNN 简况

Smith & Nephew plc是一家医疗技术公司。该公司开发、制造、营销和销售医疗器械并提供相关服务。其产品和服务包括运动医学关节修复、关节镜辅助技术(AET)、创伤和肢体、其他外科业务、膝关节植入物、髋关节植入物、高级伤口护理、高级伤口生物活性物质以及先进的伤口护理设备等。其运动医学关节修复特许经营业务为外科医生提供关节微创手术所需的一系列仪器、技术和植入物,包括软组织损伤修复以及膝盖、髋关节和肩部退行性病症治疗等。AET特许经营业务提供一系列微创手术系统和设备。创伤和肢体特许经营业务为医疗保健专业人员提供稳定严重骨折、矫正骨骼畸形、治疗关节炎和治疗软组织并发症的外科医生使用的解决方案。
展开

微牛提供Smith & Nephew plc (ADR)(NYSE-SNN)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的SNN股票新闻,以帮助您做出投资决策。

模拟交易:模拟炒股免费实操交易技能。您可用虚拟资金在真实市场环境中零成本、零风险体验交易SNN股票基本功能。